Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Brockman

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
JCI Insight|September 6, 2022
PRC2 loss drives MPNST metastasis and matrix remodelingQierra R Brockman, Amanda Scherer, Gavin R McGivney, et al.
JCI Insight|October 13, 2022
Augmenting chemotherapy with low-dose decitabine through an immune-independent mechanismWade R Gutierrez, Amanda Scherer, Jeffrey D Rytlewski, et al.
Blood|July 5, 2003
CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapyAnimesh Pardanani, Rhett P Ketterling, Stephanie R Brockman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2025
A single arm phase 2 trial of doxorubicin plus zalifrelimab (anti-CTLA-4 antibody) and balstilimab (anti-PD-1 antibody) in advanced/metastatic soft tissue sarcomasBreelyn A Wilky, Katherine A Julian, Alessandra Maleddu, et al.
British Journal of Haematology|April 16, 2003
Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemiaGordon W Dewald, Stephanie R Brockman, Sarah F Paternoster, et al.
Science Advances|August 13, 2025
Somatic CRISPR tumorigenesis and multiomic analysis reveal a pentose phosphate pathway disruption vulnerability in MPNSTsGavin R McGivney, Qierra R Brockman, Nicholas Borcherding, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 6, 2023
CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor RegressionJordan L Kohlmeyer, Joshua J Lingo, Courtney A Kaemmer, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
JCI Insight|September 6, 2022
PRC2 loss drives MPNST metastasis and matrix remodelingQierra R Brockman, Amanda Scherer, Gavin R McGivney, et al.
JCI Insight|October 13, 2022
Augmenting chemotherapy with low-dose decitabine through an immune-independent mechanismWade R Gutierrez, Amanda Scherer, Jeffrey D Rytlewski, et al.
Blood|July 5, 2003
CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapyAnimesh Pardanani, Rhett P Ketterling, Stephanie R Brockman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2025
A single arm phase 2 trial of doxorubicin plus zalifrelimab (anti-CTLA-4 antibody) and balstilimab (anti-PD-1 antibody) in advanced/metastatic soft tissue sarcomasBreelyn A Wilky, Katherine A Julian, Alessandra Maleddu, et al.
British Journal of Haematology|April 16, 2003
Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemiaGordon W Dewald, Stephanie R Brockman, Sarah F Paternoster, et al.
Science Advances|August 13, 2025
Somatic CRISPR tumorigenesis and multiomic analysis reveal a pentose phosphate pathway disruption vulnerability in MPNSTsGavin R McGivney, Qierra R Brockman, Nicholas Borcherding, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 6, 2023
CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor RegressionJordan L Kohlmeyer, Joshua J Lingo, Courtney A Kaemmer, et al.
Pageof 4